Akhilesh Pandey Selected Research

Proteome

11/2022	Pan-cancer quantitation of epithelial-mesenchymal transition dynamics using parallel reaction monitoring-based targeted proteomics approach.
1/2021	Mass Spectrometric Analysis of Urine from COVID-19 Patients for Detection of SARS-CoV-2 Viral Antigen and to Study Host Response.
1/2021	DIA-Based Proteome Profiling of Nasopharyngeal Swabs from COVID-19 Patients.
11/2020	Is the Proteome of Bronchoalveolar Lavage Extracellular Vesicles a Marker of Advanced Lung Cancer?
1/2020	Intracranial Aneurysm Biomarker Candidates Identified by a Proteome-Wide Study.
1/2020	Extra-cellular vesicles carry proteome of cancer hallmarks.
1/2018	Membrane Proteome of Invasive Retinoblastoma: Differential Proteins and Biomarkers.
1/2017	Quantitative Proteomic and Phosphoproteomic Analysis of H37Ra and H37Rv Strains of Mycobacterium tuberculosis.
1/2017	Integrating transcriptomic and proteomic data for accurate assembly and annotation of genomes.
7/2016	Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akhilesh Pandey Research Topics

Disease

90	Neoplasms (Cancer) 11/2022 - 01/2004
16	Pancreatic Neoplasms (Pancreatic Cancer) 07/2021 - 09/2004
14	Breast Neoplasms (Breast Cancer) 03/2022 - 09/2005
9	Adenocarcinoma 07/2021 - 09/2004
9	Lung Neoplasms (Lung Cancer) 01/2021 - 09/2008
9	Esophageal Squamous Cell Carcinoma 04/2018 - 01/2009
8	COVID-19 02/2022 - 01/2021
7	Carcinogenesis 03/2022 - 10/2010
7	Inflammation (Inflammations) 10/2021 - 12/2004
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 07/2013
7	Gallbladder Neoplasms (Gallbladder Cancer) 01/2021 - 04/2014
6	Neoplasm Metastasis (Metastasis) 11/2015 - 01/2011
5	Infections 02/2022 - 09/2012
5	Stomach Neoplasms (Stomach Cancer) 11/2021 - 06/2013
5	Rheumatoid Arthritis 09/2018 - 09/2013
5	Squamous Cell Carcinoma of Head and Neck 01/2017 - 11/2013
5	Carcinoma (Carcinomatosis) 07/2015 - 10/2004
4	Virus Diseases (Viral Diseases) 02/2022 - 01/2017
4	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 07/2014
4	Adenocarcinoma of Lung 01/2017 - 09/2008
4	Malaria 01/2017 - 08/2007
3	Glioma (Gliomas) 05/2021 - 07/2013
3	Parkinson Disease (Parkinson's Disease) 01/2021 - 04/2014
3	Disease Progression 08/2020 - 01/2018
3	Tuberculosis (Tuberculoses) 01/2019 - 07/2013
3	Asthma (Bronchial Asthma) 09/2018 - 01/2015
3	Retinoblastoma (Glioblastoma, Retinal) 06/2018 - 01/2016
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2017 - 03/2006
2	Melanoma (Melanoma, Malignant) 11/2021 - 04/2010
2	Glioblastoma (Glioblastoma Multiforme) 05/2021 - 06/2012
2	Acute-Phase Reaction 01/2021 - 07/2013
2	Urinary Bladder Neoplasms (Bladder Cancer) 08/2020 - 01/2020
2	Keratoconus 11/2019 - 07/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 09/2016
2	Triple Negative Breast Neoplasms 10/2017 - 10/2015
2	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2017 - 03/2016
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2015 - 03/2003
2	Fibrosis (Cirrhosis) 04/2015 - 04/2006
2	Mouth Neoplasms (Oral Cancer) 01/2015 - 01/2009
2	Nervous System Diseases (Neurological Disorders) 07/2014 - 01/2009
2	Osteoarthritis 02/2014 - 01/2014
2	Hypersensitivity (Allergy) 07/2013 - 11/2005

Drug/Important Bio-Agent (IBA)

96	Proteins (Proteins, Gene)FDA Link 11/2022 - 02/2004
44	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2004
23	ProteomeIBA 11/2022 - 02/2004
18	Phosphotransferases (Kinase)IBA 07/2021 - 09/2005
9	AntigensIBA 11/2021 - 09/2004
9	Messenger RNA (mRNA)IBA 01/2019 - 01/2009
9	DNA (Deoxyribonucleic Acid)IBA 03/2014 - 07/2002
8	Tyrosine (L-Tyrosine)FDA Link 07/2021 - 09/2008
7	IsotopesIBA 05/2022 - 01/2006
7	PhosphotyrosineIBA 07/2021 - 01/2015
7	ErbB Receptors (EGF Receptor)IBA 01/2021 - 06/2006
7	MicroRNAs (MicroRNA)IBA 10/2017 - 03/2009
6	Peptides (Polypeptides)IBA 01/2022 - 04/2010
6	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2021 - 06/2006
6	Small Interfering RNA (siRNA)IBA 09/2016 - 01/2015
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 11/2008
5	Amino Acids FDA Link 01/2018 - 01/2006
4	Pharmaceutical PreparationsIBA 02/2022 - 01/2019
4	CytokinesIBA 01/2022 - 01/2006
4	VaccinesIBA 10/2020 - 08/2007
4	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 03/2003
4	Biological ProductsIBA 01/2019 - 10/2008
4	Tyrosine Kinase InhibitorsIBA 01/2017 - 11/2008
3	Galectin 3 (LGALS3)IBA 10/2022 - 10/2004
3	Axl Receptor Tyrosine KinaseIBA 08/2021 - 11/2010
3	AntibodiesIBA 07/2021 - 02/2008
3	EnzymesIBA 05/2021 - 10/2004
3	Complement System Proteins (Complement)IBA 01/2021 - 11/2019
3	SmokeIBA 01/2021 - 09/2016
3	Glycoproteins (Glycoprotein)IBA 01/2020 - 07/2008
3	RNA (Ribonucleic Acid)IBA 01/2019 - 03/2014
3	Histones (Histone)IBA 06/2018 - 11/2005
3	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018 - 11/2008
3	Protein Kinases (Protein Kinase)IBA 01/2016 - 12/2010
3	Carrier Proteins (Binding Protein)IBA 01/2016 - 09/2005
3	Tumor Biomarkers (Tumor Markers)IBA 01/2009 - 09/2004
2	Hormones (Hormone)IBA 05/2022 - 11/2015
2	Ion Channels (Ion Channel)IBA 03/2022 - 02/2022
2	Antiviral Agents (Antivirals)IBA 02/2022 - 01/2021
2	Viral AntigensIBA 10/2021 - 01/2021
2	EphrinsIBA 07/2021 - 01/2015
2	Nucleocapsid ProteinsIBA 07/2021 - 01/2021
2	LipidsIBA 01/2021 - 01/2021
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2021 - 01/2018
2	InterferonsIBA 01/2021 - 04/2010
2	Interleukin-33IBA 09/2018 - 01/2015
2	Syk KinaseIBA 04/2018 - 07/2015
2	Transferrin Receptors (Transferrin Receptor)IBA 01/2018 - 03/2016
2	tyrosine receptor (receptor, tyrosine)IBA 01/2018 - 01/2018
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2017 - 11/2010
2	Estrogen ReceptorsIBA 10/2017 - 11/2015
2	tanespimycin (17AAG)IBA 04/2017 - 10/2008
2	Protein Isoforms (Isoforms)IBA 01/2015 - 04/2010
2	LumicanIBA 07/2013 - 03/2010
2	CalciumIBA 03/2013 - 04/2010
2	Insulin-Like Growth Factor Binding ProteinsIBA 01/2013 - 01/2006

Therapy/Procedure

16	Therapeutics 01/2020 - 10/2008
2	Drug Therapy (Chemotherapy) 04/2017 - 01/2015